Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02612376 · ClinicalTrials.gov registry record
Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 800
- Enrollment target
NCT02612376: Clinical Trial study, sponsored by University of Colorado, Denver.
NCT02612376 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 800 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02612376 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 800 participants
- Enrollment target
Study Summary
This study plans to establish a large bank of blood, cerebral spinal fluid (CSF), imaging, and clinical data. These data and samples will be used for future research into the causes of Alzheimer's disease (AD), Down Syndrome (DS) and other diseases that cause thinking and memory problems. This future research will also study how treatments for these diseases work. This research may help develop new treatments for some diseases of the nervous system and help understand these diseases better.
Primary Outcome
Whichever occurs first.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2016-02 |
| Est. Completion | 2025-05 |
Why NCT02612376 stopped before completion
NCT02612376 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02612376 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02612376 about?
NCT02612376 is a clinical study titled "Rocky Mountain Alzheimer's Disease Center Longitudinal Biomarker and Clinical Phenotyping Study". This study plans to establish a large bank of blood, cerebral spinal fluid (CSF), imaging, and clinical data. These data and samples will be used for future research into the causes of Alzheimer's disease (AD), Down Syndrome (DS) and other diseases that cause thinking and memory problems. This futur...
What is the current status of trial NCT02612376?
This trial is currently terminated. The enrollment target is 800 participants. The study started on 2016-02. Estimated completion is 2025-05.
Who is sponsoring clinical trial NCT02612376?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia